Arthur Baudewyns

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Risk-adapted Omission of Systematic Cores in PI-RADS 3 Lesions Based on Prostate-specific Antigen Density, Biopsy Route, and Targeted Core Number: A Multicentre Cohort Study.

Risk-adapted Omission of Systematic Cores in PI-RADS 3 Lesions Based on Prostate-specific Antigen Density, Biopsy Route, and Targeted Core Number: A Multicentre Cohort Study.

Journal: European urology oncology

Published: February 09, 2026

Targeted, Perilesional, and Distant Biopsies in Prostate Cancer.

Targeted, Perilesional, and Distant Biopsies in Prostate Cancer.

Journal: European urology oncology

Published: November 02, 2025

Temporal trends and clinical determinants of urinary diversion after radical cystectomy.

Temporal trends and clinical determinants of urinary diversion after radical cystectomy.

Journal: BJU international

Published: October 06, 2025

Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study.

Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study.

Journal: World journal of urology

Published: July 05, 2025

Are Patients with Prostate Imaging Reporting and Data System 5 Lesions Eligible for Active Surveillance? A Multicentric European Study.

Are Patients with Prostate Imaging Reporting and Data System 5 Lesions Eligible for Active Surveillance? A Multicentric European Study.

Journal: European urology oncology

Published: November 26, 2024

Refining clinically relevant cut-offs of prostate specific antigen density for risk stratification in patients with PI-RADS 3 lesions.

Refining clinically relevant cut-offs of prostate specific antigen density for risk stratification in patients with PI-RADS 3 lesions.

Journal: Prostate cancer and prostatic diseases

Published: May 19, 2024

Targeted microwave ablation for prostate cancer (FOSTINE1b): a prospective 'ablate-and-resect' study.

Targeted microwave ablation for prostate cancer (FOSTINE1b): a prospective 'ablate-and-resect' study.

Journal: BJU international

Published: May 14, 2024

External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.

External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.

Journal: World journal of urology

Published: April 04, 2024

The impact of prostate volume estimation on the risk-adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score.

The impact of prostate volume estimation on the risk-adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score.

Journal: World journal of urology

Published: November 20, 2023

Magnetic resonance imaging targeted biopsy in biopsy-naïve patients and the risk of overtreatment in prostate cancer: a grading issue.

Magnetic resonance imaging targeted biopsy in biopsy-naïve patients and the risk of overtreatment in prostate cancer: a grading issue.

Journal: BJU international

Published: November 09, 2023

The Added Value of Side-specific Systematic Biopsy in Patients Diagnosed by Magnetic Resonance Imaging-targeted Prostate Biopsy.

The Added Value of Side-specific Systematic Biopsy in Patients Diagnosed by Magnetic Resonance Imaging-targeted Prostate Biopsy.

Journal: European urology oncology

Published: September 27, 2023

Peering through the PSMA PET Lens: The Role of the European Association of Urology Biochemical Recurrence Risk Groups after Radical Prostatectomy.

Peering through the PSMA PET Lens: The Role of the European Association of Urology Biochemical Recurrence Risk Groups after Radical Prostatectomy.

Journal: Cancers

Published: May 03, 2023

Showing 1-12 of 14

Last Updated: 09/26/2026